BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37573325)

  • 1. Decreased cyclooxygenase-2 associated with impaired megakaryopoiesis and thrombopoiesis in primary immune thrombocytopenia.
    Zhuang X; Xu P; Ou Y; Shao X; Li Y; Ma Y; Qin S; Hua F; Zhan Y; Ji L; Qiao T; Chen H; Cheng Y
    J Transl Med; 2023 Aug; 21(1):540. PubMed ID: 37573325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
    Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
    Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice.
    Barbieri SS; Petrucci G; Tarantino E; Amadio P; Rocca B; Pesce M; Machlus KR; Ranelletti FO; Gianellini S; Weksler B; Italiano JE; Tremoli E
    Thromb Haemost; 2015 Nov; 114(6):1218-29. PubMed ID: 26272103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis.
    Khodadi E; Asnafi AA; Shahrabi S; Shahjahani M; Saki N
    Ann Hematol; 2016 Oct; 95(11):1765-76. PubMed ID: 27236577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of platelet cyclooxygenase-1 and -2 and surface glycoproteins in patients with immune thrombocytopenia and healthy individuals.
    Rubak P; Kristensen SD; Hvas AM
    Platelets; 2017 Jun; 28(4):387-393. PubMed ID: 27715371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Thrombocytopenia Plasma-Derived Exosomes Impaired Megakaryocyte and Platelet Production through an Apoptosis Pathway.
    Miao W; Song B; Shi B; Wan Q; Lv Q; Chen H; Zhu M; Zhang L; Han Y; Wu D
    Thromb Haemost; 2021 Apr; 121(4):495-505. PubMed ID: 33124021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune attack on megakaryocytes in immune thrombocytopenia.
    Petito E; Gresele P
    Res Pract Thromb Haemost; 2024 Jan; 8(1):102345. PubMed ID: 38525349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological characteristics of megakaryocytes: specific lineage commitment and associated disorders.
    Sun L; Hwang WY; Aw SE
    Int J Biochem Cell Biol; 2006; 38(11):1821-6. PubMed ID: 16730215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercholesterolemia impairs megakaryopoiesis and platelet production in scavenger receptor BI knockout mice.
    Ouweneel AB; Hoekstra M; van der Wel EJ; Schaftenaar FH; Snip OSC; Hassan J; Korporaal SJA; Van Eck M
    Atherosclerosis; 2019 Mar; 282():176-182. PubMed ID: 30278990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of chronic immune thrombocytopenic purpura.
    McMillan R
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
    Gernsheimer TB
    Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietic effect of VPAC1 inhibition during megakaryopoiesis.
    Peeters K; Loyen S; Van Kerckhoven S; Stoffels K; Hoylaerts MF; Van Geet C; Freson K
    Br J Haematol; 2010 Oct; 151(1):54-61. PubMed ID: 20735399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody against integrin α
    Zeng DF; Chen F; Wang S; Chen SL; Xu Y; Shen MQ; Du CH; Wang C; Kong PY; Cheng TM; Su YP; Wang JP
    J Thromb Haemost; 2018 Sep; 16(9):1843-1856. PubMed ID: 29953749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.
    Arnold DM; Nazi I; Toltl LJ; Ross C; Ivetic N; Smith JW; Liu Y; Kelton JG
    Eur J Haematol; 2015 Dec; 95(6):532-7. PubMed ID: 25684257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role and mechanism of miR-557 in inhibiting the differentiation and maturation of megakaryocytes in immune thrombocytopenia.
    Wang Y; Guo Y; Zhang X; Zhao H; Zhang B; Wu Y; Zhang J
    RNA Biol; 2021 Nov; 18(11):1953-1968. PubMed ID: 33586614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Developments in the Pathophysiology and Management of Primary Immune Thrombocytopenia.
    Althaus K; Faul C; Bakchoul T
    Hamostaseologie; 2021 Aug; 41(4):275-282. PubMed ID: 33348391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia.
    Liu Y; Zuo X; Chen P; Hu X; Sheng Z; Liu A; Liu Q; Leng S; Zhang X; Li X; Wang L; Feng Q; Li C; Hou M; Chu C; Ma S; Wang S; Peng J
    Signal Transduct Target Ther; 2022 Oct; 7(1):347. PubMed ID: 36202780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of Autoimmune Thrombocytopenia: Current Insight with a Focus on Thrombopoiesis.
    Marini I; Bakchoul T
    Hamostaseologie; 2019 Aug; 39(3):227-237. PubMed ID: 30802916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia.
    Zhou H; Hou Y; Liu X; Qiu J; Feng Q; Wang Y; Zhang X; Min Y; Shao L; Liu X; Li G; Li L; Yang L; Xu S; Ni H; Peng J; Hou M
    Thromb Haemost; 2015 May; 113(5):1021-34. PubMed ID: 25566808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets in ITP: Victims in Charge of Their Own Fate?
    Nelson VS; Jolink AC; Amini SN; Zwaginga JJ; Netelenbos T; Semple JW; Porcelijn L; de Haas M; Schipperus MR; Kapur R
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.